EPISODE · Nov 19, 2024 · 3 MIN
Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study
from Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM · host Annenberg Center for Health Sciences
Author: Strober J, et al.Overview Provided by Nicolas Silvestri, MD
Embed this episode
NOW PLAYING
Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study
0:00
3:26
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM?
This episode is 3 minutes long.
When was this Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM episode published?
This episode was published on November 19, 2024.
Can I download this Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!